270 related articles for article (PubMed ID: 10793824)
21. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Chan TK; Todd D; Tso SC
Br Med J; 1976 Nov; 2(6046):1227-9. PubMed ID: 990860
[TBL] [Abstract][Full Text] [Related]
22. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Fraser IM; Vesell ES
J Pharmacol Exp Ther; 1968 Jul; 162(1):155-65. PubMed ID: 5656594
[No Abstract] [Full Text] [Related]
23. [Clinical importance of hemolysis in the prophylactic treatment of malaria using primaquine on persons with a glucose-6-phosphate dehydrogenase deficit].
Bronshteĭn AM; Ozeretskovskaia NN; Benediktov II; Ibragimov GI; Dzhafarova SKh
Med Parazitol (Mosk); 1975; 44(3):282-8. PubMed ID: 1177819
[No Abstract] [Full Text] [Related]
24. Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.
Uthman OA; Graves PM; Saunders R; Gelband H; Richardson M; Garner P
Malar J; 2017 Aug; 16(1):346. PubMed ID: 28830424
[TBL] [Abstract][Full Text] [Related]
25. Drug-induced glucose-6-phosphate dehydrogenase deficiency-related hemolysis risk assessment.
Yang Y; Li Z; Nan P; Zhang X
Comput Biol Chem; 2011 Jun; 35(3):189-92. PubMed ID: 21704265
[TBL] [Abstract][Full Text] [Related]
26. Acute haemolytic crisis due to concomitant presence of infection and possible altered acetaminophen catabolism in a Philipino child carrying the G6PD-Vanua Lava mutation.
Minucci A; De Luca D; Torti E; Concolino P; Maurizi P; Giardina B; Zuppi C; Capoluongo E
Ann Clin Biochem; 2011 May; 48(Pt 3):282-5. PubMed ID: 21441392
[TBL] [Abstract][Full Text] [Related]
27. Consideration of ethics in primaquine therapy against malaria transmission.
Baird JK; Surjadjaja C
Trends Parasitol; 2011 Jan; 27(1):11-6. PubMed ID: 20846906
[TBL] [Abstract][Full Text] [Related]
28. The survival of glucose-6-phosphate dehydrogenase--deficient erythrocytes in patients with typhoid fever on chloramphenicol therapy.
Chan TK; Chesterman CN; McFadzean AJ; Todd D
J Lab Clin Med; 1971 Feb; 77(2):177-84. PubMed ID: 5540765
[No Abstract] [Full Text] [Related]
29. [Hemocoagulation disturbances in drug-provoked hemolysis in persons with glucose-6-phosphate dehydrogenase deficiency].
Ozeretskovskaia NN; Bronshteĭn AM; Benediktov NI; Ibragimov G; Dzhafarova S
Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):45-8. PubMed ID: 1273064
[No Abstract] [Full Text] [Related]
30. Change of deformability and Heinz body formation in G6PD-deficient erythrocytes treated with 5-hydroxy-6-desmethylprimaquine.
Thompson SF; Fraser IM; Strother A; Bull BS
Blood Cells; 1989; 15(2):443-52; discussion 453-4. PubMed ID: 2765673
[TBL] [Abstract][Full Text] [Related]
31. [Scanning electron microscopic study of the morphological changes induced by acetylsalicylic acid in therapeutic doses in the red blood cells of a patient with a very severe G6PD deficiency and clinical manifestations of favism].
Pazzi A; Accardo G; Aleotti A; Saletti G
G Clin Med; 1980 Jun; 61(6):435-43. PubMed ID: 7450362
[No Abstract] [Full Text] [Related]
32. Erythrocyte glucose-6-phosphate dehydrogenase and glutathione deficiency in sheep.
Maronpot RR
Can J Comp Med; 1972 Jan; 36(1):55-60. PubMed ID: 4258546
[TBL] [Abstract][Full Text] [Related]
33. [Glucose-6-phosphate dehydrogenase deficiency in Algeria].
Benabadji M; Benlatrache C; Merad F; Suaudeau C; Benmoussa M; Kornprobst G; Cladel G
Sem Hop; 1977 Apr; 53(16):899-904. PubMed ID: 197609
[TBL] [Abstract][Full Text] [Related]
34. [Glucose-6-phosphate dehydrogenase deficiency and other erythrocyte enzyme abnormalities].
Pohl A; Blechschmidt E; Moser K
Wien Klin Wochenschr; 1984 Jul; 96(14):542-8. PubMed ID: 6089445
[TBL] [Abstract][Full Text] [Related]
35. Glucose-6-phosphate dehydrogenase deficiency in two returning Operation Iraqi Freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria.
Carr ME; Fandre MN; Oduwa FO
Mil Med; 2005 Apr; 170(4):273-6. PubMed ID: 15916292
[TBL] [Abstract][Full Text] [Related]
36. Haemolysis with anti-malarial drugs in glucose 6 phosphate dehydrogenase deficiency.
Bhalla A; Jajoo UN; Jain AP; Kalantri SP
J Ayub Med Coll Abbottabad; 2004; 16(3):75-8. PubMed ID: 15631380
[No Abstract] [Full Text] [Related]
37. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
38. Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency.
Reeve PA; Toaliu H; Kaneko A; Hall JJ; Ganczakowski M
J Trop Med Hyg; 1992 Oct; 95(5):349-51. PubMed ID: 1404560
[No Abstract] [Full Text] [Related]
39. Central retinal vein occlusion in an Army ranger with glucose-6-phosphate dehydrogenase deficiency.
Kotwal RS; Butler FK; Murray CK; Hill GJ; Rayfield JC; Miles EA
Mil Med; 2009 May; 174(5):544-7. PubMed ID: 20731290
[TBL] [Abstract][Full Text] [Related]
40. Catalase activity in normal and glucose-6-phosphate dehydrogenase deficient red cells.
Ezra R; Szeinberg A; Sheba C
Isr J Med Sci; 1965 Jul; 1(4):847-50. PubMed ID: 5856129
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
